← back to Newsroom

Inception Fertility Announces 37 Abstracts Accepted, to be Presented at the 2025 ASRM Scientific Congress

Physicians across Inception Fertility’s global network, The Prelude Network, to present new findings in reproductive medicine that further investigate causes of infertility and improving treatments, outcomes

October 23, 2025 9:56 AM
EDT
(EZ Newswire)
Share article
Source: Inception Fertility (EZ Newswire)
Source: Inception Fertility (EZ Newswire)

Inception Fertility™ (Inception), the largest provider of comprehensive fertility products and services in North America, announces today that 37 abstracts from its clinical network, The Prelude Network® (Prelude), have been accepted by the American Society for Reproductive Medicine (ASRM) to be presented at the 2025 ASRM Scientific Congress, taking place October 25-29, 2025 in San Antonio, Texas.

ASRM is a professional organization dedicated to advancing the science and practice of reproductive medicine. Its annual Scientific Congress is a gathering of multi-disciplinary professionals who share the latest scientific breakthroughs and discoveries in reproductive endocrinology and infertility.

“Reproductive medicine continues to evolve rapidly, driven by the passion and innovation of physicians dedicated to helping more patients build their families,” said TJ Farnsworth, founder and CEO of Inception Fertility, the parent company of Prelude. “We’re deeply grateful to our researchers and clinicians whose commitment continues to explore what’s possible in reproductive care.”

Physicians from across Prelude's global network, including NYU Langone Fertility CenterReproductive Medicine Group, Indiana Reproductive Institute, Aspire Houston Fertility Institute, and Regional Fertility Program in Canada, will present abstracts on some of the most pressing topics in reproductive medicine, including mosaic embryos, genetics, LGBTQ+ family building, oncofertility, male factor infertility, among others.

“The ongoing evolution of reproductive medicine is driven by research that directly improves patient outcomes and quality of care for the millions impacted by infertility,” said Dr. Jamie Grifo, Program Director at NYU Langone Fertility Center and Chief Executive Physician at Inception Fertility. “Prelude’s strong presence at the 2025 ASRM Scientific Congress underscores our leadership in advancing the science of reproductive medicine, and I commend my colleagues for their meaningful contributions to this important work.”

For media attending the 2025 ASRM Scientific Congress who would like to connect on-site with Prelude physicians to further discuss their abstracts, or for media interested in reporting in any one of these studies, please contact Mia Humphreys at mhumphreys@kruppagency.com.

About Inception Fertility

Inception Fertility™ (Inception) is a family of fertility brands committed to helping patients build their own families. Built by patients for patients, Inception's purpose is to achieve the highest bar in experience, science and medicine in an effort to enhance each patient's experience and achieve better outcomes. 

Inception's medical experts are leading pioneers in fertility care. Our doctors are some of the first to use breakthrough assisted reproductive technologies (ART) – including in vitro fertilization (IVF), preimplantation genetic testing (PGT) and fertility preservation services – and they continue to lead the industry by building on these technologies by through development, research and thought leadership. 

Through its growing family of national organizations — which includes The Prelude Network®, the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America; MyEggBank®, one of the largest frozen donor egg banks in North America; BUNDL Fertility™, a multi-cycle fertility service bundling program; HavenCryo™, a long-term reproductive preservation and storage solution provider and NutraBloom®, a premium lifestyle brand with expertly formulated supplements to support individuals' health and wellness goals for preconception — Inception is working to deliver on its promise to push the envelope of what is possible for exceeding patient expectations.

To learn more about the Inception Research Institute, please visit inceptionfertility.com/inception-research-institute/. You can see a full of active research studies by visiting fertilitystudies.com.

About The Prelude Network

The Prelude Network® (Prelude), the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America, is the clinic network of Inception Fertility™ — a family of fertility brands that touches every part of the fertility journey, including diagnostics and treatment to financial accessibility.

Each clinic, as part of Prelude, is committed to delivering the highest level of personalized fertility care by the nation's leading reproductive endocrinologists, embryologists and practitioners by focusing on an excellence in science, medicine and the patient experience. The growing Prelude Network has more than 90 total locations nationwide, offering a wide range of fertility services including egg freezing, IVF, genetic testing, LGBTQ+ fertility options, and egg/embryo storage, among others.

Those clinics within Prelude include Aspire Fertility Austin (Texas); Aspire Fertility Dallas (Texas); Aspire Fertility McAllen (Texas); Aspire Fertility San Antonio (Texas); Aspire Houston Fertility Institute (Texas); Advanced Fertility Center of Chicago (Illinois); Center for Reproductive Medicine (Florida); Indiana Fertility Institute (Indiana); IVFMD (Florida); Main Line Fertility (Pennsylvania); NYU Langone Fertility Center (New York); NYU Langone RSNY (New York); Pacific Centre for Reproductive Medicine (Canada); Pacific Fertility Center (California); Regional Fertility Program (Canada); Reproductive Biology Associates (Georgia); Reproductive Science Center of New Jersey (New Jersey); Tennessee Fertility Institute (Tennessee), and The Reproductive Medicine Group (Florida).

Media Contact

Mia Humphreys
mhumphreys@kruppagency.com
+1 239-297-6592

More from this Source
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Loading items...